Approximately 40% of TRAF7 altered meningiomas carry a recurrent loss-of-function KLF4-K409Q mutation that impairs this negative feedback mechanism, thereby allowing for the promotion of meningeal cell growth described above (Clark et al. 2013). Here, TRAF7 is linked to meningioma.